Immunology

  1. Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19

    1. Mads Delbo Larsen
    2. Erik L. de Graaf
    3. Myrthe E. Sonneveld
    4. H. Rosina Plomp
    5. Federica Linty
    6. Remco Visser
    7. Maximilian Brinkhaus
    8. Tonći Šuštić
    9. Steven W. de Taeye
    10. Arthur E.H. Bentlage
    11. Jan Nouta
    12. Suvi Natunen
    13. Carolien A. M. Koeleman
    14. Susanna Sainio
    15. Neeltje A. Kootstra
    16. Philip J.M. Brouwer
    17. Rogier W. Sanders
    18. Marit J. van Gils
    19. Sanne de Bruin
    20. Alexander P.J. Vlaar
    21. Amsterdam UMC COVID-19 biobank study group
    22. Hans L. Zaaijer
    23. Manfred Wuhrer
    24. C. Ellen van der Schoot
    25. Gestur Vidarsson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Controlling the SARS-CoV-2 spike glycoprotein conformation

    1. Rory Henderson
    2. Robert J. Edwards
    3. Katayoun Mansouri
    4. Katarzyna Janowska
    5. Victoria Stalls
    6. Sophie M. C. Gobeil
    7. Megan Kopp
    8. Dapeng Li
    9. Rob Parks
    10. Allen L. Hsu
    11. Mario J. Borgnia
    12. Barton F. Haynes
    13. Priyamvada Acharya

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection

    1. Leticia Kuri-Cervantes
    2. M. Betina Pampena
    3. Wenzhao Meng
    4. Aaron M. Rosenfeld
    5. Caroline A.G. Ittner
    6. Ariel R. Weisman
    7. Roseline Agyekum
    8. Divij Mathew
    9. Amy E. Baxter
    10. Laura Vella
    11. Oliva Kuthuru
    12. Sokratis Apostolidis
    13. Luanne Bershaw
    14. Jeannete Dougherty
    15. Allison R. Greenplate
    16. Ajinkya Pattekar
    17. Justin Kim
    18. Nicholas Han
    19. Sigrid Gouma
    20. Madison E. Weirick
    21. Claudia P. Arevalo
    22. Marcus J. Bolton
    23. Eileen C. Goodwin
    24. Elizabeth M. Anderson
    25. Scott E. Hensley
    26. Tiffanie K. Jones
    27. Nilam S. Mangalmurti
    28. Eline T. Luning Prak
    29. E. John Wherry
    30. Nuala J. Meyer
    31. Michael R. Betts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2

    1. Ge Liu
    2. Brandon Carter
    3. Trenton Bricken
    4. Siddhartha Jain
    5. Mathias Viard
    6. Mary Carrington
    7. David K. Gifford

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease

    1. U. Radzikowska
    2. M. Ding
    3. G. Tan
    4. D. Zhakparov
    5. Y. Peng
    6. P. Wawrzyniak
    7. M. Wang
    8. S. Li
    9. H. Morita
    10. C. Altunbulakli
    11. M. Reiger
    12. AU. Neumann
    13. N. Lunjani
    14. C. Traidl-Hoffmann
    15. K. Nadeau
    16. L. O’Mahony
    17. CA. Akdis
    18. M. Sokolowska

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein

    1. Anna Z. Wec
    2. Daniel Wrapp
    3. Andrew S. Herbert
    4. Daniel Maurer
    5. Denise Haslwanter
    6. Mrunal Sakharkar
    7. Rohit K. Jangra
    8. M. Eugenia Dieterle
    9. Asparouh Lilov
    10. Deli Huang
    11. Longping V. Tse
    12. Nicole V. Johnson
    13. Ching-Lin Hsieh
    14. Nianshuang Wang
    15. Juergen H. Nett
    16. Elizabeth Champney
    17. Irina Burnina
    18. Michael Brown
    19. Shu Lin
    20. Melanie Sinclair
    21. Carl Johnson
    22. Sarat Pudi
    23. Robert Bortz
    24. Ariel S. Wirchnianski
    25. Ethan Laudermilch
    26. Catalina Florez
    27. J. Maximilian Fels
    28. Cecilia M. O’Brien
    29. Barney S. Graham
    30. David Nemazee
    31. Dennis R. Burton
    32. Ralph S. Baric
    33. James E. Voss
    34. Kartik Chandran
    35. John M. Dye
    36. Jason S. McLellan
    37. Laura M. Walker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. CoV-AbDab: the Coronavirus Antibody Database

    1. Matthew I. J. Raybould
    2. Aleksandr Kovaltsuk
    3. Claire Marks
    4. Charlotte M. Deane

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement

    1. Wen-Hsiang Chen
    2. Xinrong Tao
    3. Anurodh Agrawal
    4. Abdullah Algaissi
    5. Bi-Hung Peng
    6. Jeroen Pollet
    7. Ulrich Strych
    8. Maria Elena Bottazzi
    9. Peter J. Hotez
    10. Sara Lustigman
    11. Lanying Du
    12. Shibo Jiang
    13. Chien-Te K. Tseng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2

    1. Ang Gao
    2. Zhilin Chen
    3. Florencia Pereyra Segal
    4. Mary Carrington
    5. Hendrik Streeck
    6. Arup K. Chakraborty
    7. Boris Julg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome

    1. Stephen N. Crooke
    2. Inna G. Ovsyannikova
    3. Richard B. Kennedy
    4. Gregory A. Poland

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 39 of 173 Next